The complete nucleotide sequences of the genomes of dengue-1 virus virulent 45AZ5 PDK-0 and attenuated vaccine candidate strain 45AZ5 PDK-27 have been determined and compared with the dengue-1 virus Western Pacific (West Pac) 74 parent strain from which 45AZ5 PDK-0 was derived. Twenty-five (0n23 %) nucleotide and 10 (0n29 %) amino acid substitutions occurred between parent strain dengue-1 virus West Pac 74 and virulent strain 45AZ5 PDK-0, which was derived from the parent by serial passage in diploid foetal rhesus lung (FRhL-2) and mutagenized with 5-azacytidine.
Introduction
The four serotypes of dengue (DEN) virus belong to the genus Flavivirus in the family Flaviviridae. These are singlestranded positive-sense RNA viruses with a genome of about 11 000 bases that codes for three structural proteins, C-prM-E ; seven nonstructural proteins, NS1-NS2a-NS2b-NS3-NS4a-NS4b-NS5 ; and short non-coding regions on both the 5h and 3h ends (Chambers et al., 1990) . The DEN viruses are responsible for millions of infections each year throughout the tropical and subtropical regions of the world (Monath, 1994) . Disease resulting from DEN virus infection ranges from a mild self-limiting fever to life-threatening haemorrhagic fever and shock (Halstead, 1980) . Because of its widespread geographical distribution, large number of annual cases and the severity of disease, the development of vaccines to prevent DEN virus infections is a high priority. These substitutions were preserved in the 45AZ5 PDK-27 vaccine. 45AZ5 PDK-0 and PDK-27 strains, which differ by 27 passages in primary dog kidney (PDK) cells, show 25 (0n23 %) nucleotide and 11 (0n32 %) amino acid divergences. These comparative studies suggest that the changes which occurred between the West Pac 74 and 45AZ5 PDK-0 strains may alter the biological properties of the virus but may not be important for attenuation. Important nucleotide base changes responsible for attenuation accumulated between 45AZ5 PDK-0 and 27.
One approach to developing DEN vaccines used by several research groups in recent years has been the selection of liveattenuated candidate vaccines by serial passage of wild DEN viruses in primary dog kidney (PDK) cell cultures (Eckels et al., 1984 ; Bhamarapravati et al., 1987 ; Edelman et al., 1994) . This approach has produced a number of DEN virus strains that have various degrees of reduced virulence for humans compared to the parent virus strains from which they were derived. To help define the molecular basis of virulence in DEN it is useful, as an initial step, to compare the nucleotide sequences of such parent and derived attenuated DEN virus strains. The comparison of the virulent parent DEN-2 virus strain 16681 with an attenuated strain derived by 53 serial passages in PDK cells revealed 53 nucleotide changes resulting in 27 amino acid changes scattered throughout the genome (Blok et al., 1992) .
To help determine which changes are actually responsible for loss of virulence and which may be unimportant, it would be useful to compare the sequences of strains at different PDK passage levels in the progression to attenuation. Recently, vaccination of human volunteers with a series of different PDK passage level DEN-1 virus strains derived from the 45AZ5 strain was reported (Edelman et al., 1994) . This study showed that with progressive passage in PDK cell culture, the level of attenuation for humans increased. The purpose of the present study was to identify the nucleotide and amino acid changes that occurred in DEN-1 during the process of progressive attenuation.
Methods
History of virus strains. The parent DEN-1 strain used in these studies, 45AZ5 PDK-0, was derived from the human isolate, West Pac 74, made from a mild case of dengue fever during an outbreak on Nauru Island in the Western Pacific in 1974 (Repik et al., 1983) . The West Pac 74 virus was serially passaged in a diploid foetal rhesus lung cell line (FRhL), plaque cloned, mutagenized with 5-azacytidine and again plaque cloned, and amplified in FRhL cells to prepare a virus vaccine stock, 45AZ5 PDK-0 (McKee et al., 1987) . The resulting virus vaccine preparation, which showed the altered properties of small plaque size, temperature sensitivity and loss of neurovirulence for mice, was administered to two human volunteers. Both volunteers developed unmodified dengue fever indicating that 45AZ5 PDK-0 was not attenuated. Subsequently, 45AZ5 PDK-0 was serially passed in PDK cells in a further attempt to attenuate this strain (Edelman et al., 1994) . Strains from PDK passage levels 10, 20 and 27 were passaged three time in FRhL cells to prepare final virus vaccine stocks which were evaluated in monkeys and human volunteers. All three of these strains showed a reduced duration and titre of viraemia in monkeys compared to the 45AZ5 PDK-0 parent strain (K. H. Eckels, unpublished data) and when inoculated in human volunteers a trend of reduced virulence with progressive passage in PDK cells was reported (Edelman et al., 1994) . In brief, the PDK-10 strain produced symptoms in a smaller proportion of volunteers than the parent PDK-0 strain, but was still considered too reactogenic. The PDK-20 passage level strain was considered to be adequately attenuated and immunogenic, while the PDK-27 strain was overly attenuated and produced seroconversions in less than half of the volunteers.
RT-PCR. Viral RNA was extracted directly from the vaccine stocks prepared in FRhL cells or after a single amplification passage of virus in C6\36 cell cultures using a mixture of guanidine isothiocyanatephenol-chloroform by modified methods described previously (Chomczynski & Sacchi, 1987) . The RT-PCR products from different regions of the viral genome were generated as described by Puri et al. (1994) using specific overlapping primer sets designed from published data (Mason et al., 1987) .
Sequence analysis of PCR products and cloned DNA. The double-stranded PCR product was directly sequenced on a Genesis 2000 DNA Analysis System automatic sequencer utilizing fluorescent dideoxy terminators (Shaffer et al., 1990) . To produce cloned DNA for sequencing, PCR products generated from different regions of the viral genome were cleaved with the appropriate restriction enzymes and cloned into pUC19 using standard methods (Maniatis et al., 1982) . Cloned DNA was amplified with pUC19 biotinylated universal primers and sequenced with nested pUC19 universal primers as mentioned above. For each region of the genome compared, two or three clones were sequenced from each virus strain.
Sequencing of the termini of viral RNA was done by 5h-3h ligation followed by RT-PCR as described previously (Mandl et al., 1991) . Nucleic acid sequences and deduced amino acid sequence comparison and alignments were done with Sequencer version 3.0 (Gene Code Corp.). 10 114  A  T  T  3h end  10 280  T  T  C  10 338  A  A  G  10 449  G  G  T  10 453 G G T
Results
The entire genomes of the 45AZ5 PDK-0 and 45AZ5 PDK-27 DEN-1 strains were sequenced. Only the areas of the genome where nucleotide changes resulted in amino acid substitutions or where nucleotide changes occurred in the noncoding regions of the genome between 45AZ5 PDK-0 and 45AZ5 PDK-27 were sequenced for the 45AZ5 PDK-10 and 45AZ5 PDK-20 DEN-1 strains. A partial sequence of the DEN-1 West Pac 74 strain had been previously published (Mason et al., 1987) , and the remainder of the genome was sequenced for comparison in this study.
There were 25\10 735 (0n23 %) nucleotide changes between the two DEN-1 virus strains West Pac 74 and 45AZ5 PDK-0, of which 15 were silent, resulting in 10\3392 (0n29 %) amino acid differences (Table 1 ). The nucleotide changes between West Pac 74 and 45AZ5 PDK-0 occurred throughout the coding region of the genome. The 10 amino acid changes were located as follows : 2 in the E protein, 3 in NS3, 2 in NS4A and 3 in NS5. All of the substitutions that occurred between West Pac 74 and 45AZ5 PDK-0 remained in 45AZ5 PDK-27, and an additional 25 nucleotide changes occurred resulting in 11 amino acid changes ( Table 1 ). The nucleotide changes were distributed throughout the genome in both the coding and noncoding regions. Of the 11 amino acid changes, most occurred in the E protein (5) with the additional changes occurring in NS1 (1), NS2a (1), NS3 (2) and NS5 (2). Four nucleotide changes were located in the 3h non-coding region. In total, 50\10 735 (0n47 %) nucleotide mutations occurred that resulted in 21\3392 (0n62 %) amino acid differences between the West Pac 74 and 45AZ5 PDK 27 DEN-1 strains. The E protein had the greatest number (7) as well as the highest proportion (1n4 %) of amino acid changes. No changes were found in the 5h non-coding region, the C protein or the NS4b protein.
As would be expected if most nucleotide changes occurred by base mispairing during RNA replication, transition type point mutations were ten times more common than transversions. Nucleotide mutations that resulted in amino acid substitutions or changes in the 3h non-coding end of the genome between 45AZ5 PDK-0 and 45AZ5 PDK-27 were confirmed in 45AZ5 PDK-10 and 45AZ5 PDK-20 (Table 2) . Six of the 15 mutations occurred between 45AZ5 PDK-0 and 45AZ5 PDK-10 resulting in 4 amino acid substitutions and 2 nucleotide changes in the 3h non-coding region. Only one additional nucleotide mutation occurred between 45AZ5 PDK-10 and 45AZ5 PDK-20, but this single change also resulted in an amino acid change in the E protein. The remaining 8 changes occurred between passages PDK-20 and PDK-27 resulting in 6 amino acid changes and the 2 additional changes in the 3h noncoding region.
Discussion
We found multiple nucleotide and amino acid changes occurring in DEN-1 virus over the course of attenuation in PDK cells (Table 1) . Similar results have been reported previously in studies on other flaviviruses comparing the genomes of virulent parent strains with attenuated strains derived by serial propagation in cell culture systems (Hahn et al., 1987 ; Aihara et al., 1991 ; Blok et al., 1992) . An advantage of the current study, however, was the availability of a series of DEN-1 virus strains (45AZ5 PDK-10, PDK-20 and PDK-27) derived from a common parent (45AZ5 PDK-0) by passage in cell cultures that showed progressive attenuation for human volunteers as the passage level increased.
The 25 nucleotide and 10 amino acid changes that occurred in 45AZ5 PDK-0 compared to its parent, West Pac 74, as a result of chemical mutagenesis and serial passage in FRhL cells did not result in attenuation. In fact, both volunteers who received the 45AZ5 PDK-0 vaccine strain of DEN-1 not only developed unmodified DEN fever, but developed uncharacteristically long viraemias beginning on day one postinoculation and lasting 12-19 days (McKee et al., 1987) . However, the additional 25 nucleotide point mutations resulting in 11 amino acid changes that occurred between 45AZ5 PDK-0 and 45AZ5 PDK-27 did result in attenuation since none of the volunteers inoculated with the passage level 27 vaccine strain developed fever or viraemia, and only 4 out of 10 seroconverted for DEN-1 neutralizing antibody (Edelman et al., 1994) . Because the degree of attenuation for humans appeared to increase with PDK passage level (PDK-27 PDK-20 PDK-10 PDK-0) multiple mutations probably contributed to the high level of attenuation observed with the 45AZ5 PDK-27 vaccine strain.
The E protein is the major surface antigen in flaviviruses (Chambers et al., 1990 ). This protein is probably responsible for binding to cellular receptors and for membrane fusion, and contains the major epitopes for inducing neutralizing antibody. In the present study, only 5 amino acid changes occurred in the E protein during PDK passage. One of the two changes that occurred between passage levels 0-10 was at amino acid 156 (aa 436 in the polyprotein) of the E protein and involved the substitution of isoleucine for threonine. The same substitution at amino acid 155 in the E protein of DEN-4 ablated a glycosylation site resulting in increased mouse neurovirulence (Kawano et al., 1993) . The other amino acid substitution that occurred in the E protein between passage levels 0-10 was a conservative change in the transmembrane anchor region which would be unlikely to affect viral structure or function.
The single amino acid substitution in E between PDK passage levels 10-20 involved a charge change (glutamic acid to lysine). Since this is the only nucleotide change that occurred between these passage levels, it is assumed that it was responsible for the reduced virulence of the 45AZ5 PDK-20 strain compared to the 45AZ5 PDK-10 DEN-1 virus strain. Several studies with flaviviruses have suggested amino acid substitutions in the E protein that result in charge changes could affect mouse neurovirulence (Chen et al., 1995 ; Sumiyoshi et al., 1995) . The amino acid substitution in the yellow fever virus E protein mentioned previously that resulted in increased neurovirulence for humans also involved a charge change (Jennings et al., 1994) . Such non-conservative amino acid substitutions are perhaps more likely to induce structural changes in the E protein that could affect function than substitutions that do not alter the charge profile. Of the two changes that occurred in the E protein between passage levels 20-27, the substitution of aspartic acid for aspargine at amino acid 366 (residue 646 in the polyprotein) also involved a charge change and occurred in an area, domain B, implicated in the attachment of flaviviruses to the cell receptor (Rey et al., 1995) . Amino acid changes in this area have been shown to affect mouse neurovirulence for several other flaviviruses including Murray Valley encephalitis, tick-borne encephalitis, louping ill and Japanese encephalitis (Lobigs et al., 1990 ; Holzmann et al., 1990 ; Jiang et al., 1993 ; Cecilia & Gould, 1991) . A total of 6 amino acid changes occurred in viral nonstructural proteins between 45AZ5 PDK-0 and PDK-27 (Table 1) . Both NS1 and NS2a had a single amino acid change. The function of these two proteins is not well defined (Chambers et al., 1990) . Two changes occurred in NS3, one between passage levels 0-10 and one between passage levels 20-27. The N terminus of NS3 has been shown to function as part of a virus-encoded protease that helps process the viral polyprotein and the C terminus has been implicated by sequence homology to function as the viral helicase (Wengler & Wengler, 1991 ; Gorbalenya et al., 1989) . Neither one of these substitutions directly involved conserved motifs identified as part of the protease or helicase active sites ; however, they both involved charge changes which could conceivably affect other areas of NS3 through structural rearrangements. Two changes also occurred in NS5 between passage levels 20-27. Like NS3, NS5 also is apparently a multifunctional protein functioning as the viral RNA-dependent RNA polymerase and as the methyltransferase (Batholomeusz & Wright, 1993 ; Koonin, 1993) . One of the changes, cysteine to arginine, occurred within part of the motif for the putative methyltransferase potentially interfering with the capping of the 5h-terminal end of the genome. The other substitution in NS5 did not occur within either putative motif and did not involve a charge or hydrophobic profile change.
The point mutations in the 3h non-coding region of the viral genome that occurred between passage levels 0-10 and passage levels 20-27 could potentially affect virulence. This region has been shown to contain a stable secondary structure and short conserved sequences which probably play an important role in RNA replication and translation regulation (Brinton et al., 1986 ; Chambers et al., 1990) .
Sequence comparison of virulent and attenuated virus strains is a useful first step in mapping mutations that potentially contribute to the attenuation process. However, when multiple differences exist between these strains, defining which mutations are important for attenuation and which are not cannot be accomplished by this approach alone. The information gained by such genomic comparison can be used, however, to systematically construct a series of virus strains containing single point mutations by site-directed mutagenesis of full-length infectious cDNA (Lai et al., 1991 ; Kapoor et al., 1995) . For DEN-1, full-length infectious cDNA has not been reported. One of the projects currently in progress in our laboratory is to make such an infectious clone for DEN-1. Comparing the sequences of multiple virus strains that have been derived from the same virulent parent but possess different levels of attenuation as we have done with DEN-1 in this study will reduce the number of mutations that have to be tested to define the genetic basis of virulence for humans.
